Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
R. Aalbers (Groningen, Netherlands). Detrimental effects of Beta-blockers in COPD. Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in COPD: Beneficial effects of roflumilast Source: International Congress 2017 – COPD management Year: 2017 Cardioprotective effects of inhaled corticosteroid-containing combination therapy in COPD Source: Eur Respir J, 53 (2) 1802420; 10.1183/13993003.02420-2018 Year: 2019 Is the coprescription of Beta-blockers and Beta2-agonists justified in patients with coexisting COPD and CHF? Source: Annual Congress 2009 - Beta-blockers may now be beneficial in asthma and COPD Year: 2009 Beta-blockers and COPD: the show must go on Source: Eur Respir J 2016; 48: 600-603 Year: 2016 Treating systemic effects of COPD Source: Annual Congress 2009 - Emerging trends in the therapy of COPD Year: 2009 Treating systemic effects of COPD Source: Annual Congress 2012 - PG9 Progress on the treatment of COPD Year: 2012 Using cardioselective beta-blockers in patients with cardiovascular diseases and COPD Source: Eur Respir J 2005; 26: Suppl. 49, 294s Year: 2005 Persistency of antioxidant/antiinflammatory effects of erdosteine treatment in COPD Source: Annual Congress 2009 - Drug effects in COPD Year: 2009 Pharmacological actions of statins: potential utility in COPD Source: Eur Respir Rev 2009; 18: 222-232 Year: 2009 Using cardioselective beta-blockers in patients with cardiovascular diseases and asthma Source: Eur Respir J 2007; 30: Suppl. 51, 69s Year: 2007 Serotonergic antidepressants in COPD: beneficial or harmful? Source: Eur Respir J, 52 (1) 1801095; 10.1183/13993003.01095-2018 Year: 2018 Inhaled glucocorticosteroid treatment effects on pulmonary artery pressure and cardiac function in healthy smokers Source: International Congress 2016 – Pulmonary hypertension: the clinic I Year: 2016 Cardiopulmonary interactions with beta-blockers and inhaled therapy in COPD. Source: International Congress 2017 – Management of COPD Year: 2017 Predictors of effects and adverse effects of pirfenidone on idiopathic pulmonary fibrosis Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Effectiveness and safety of concurrent beta-blockers and inhaled bronchodilators in COPD with cardiovascular comorbidities Source: Eur Respir Rev, 26 (145) 160123; 10.1183/16000617.0123-2016 Year: 2017 Anti-inflammatory effects of targeted lung denervation in patients with COPD Source: Eur Respir J 2015; 46: 1489-1492 Year: 2015 Concurrent use of long-acting bronchodilators in COPD and the risk of adverse cardiovascular events Source: Eur Respir J, 49 (5) 1602245; 10.1183/13993003.02245-2016 Year: 2017 The effect of statin therapy in patients with chronic obstructive airway disease Source: International Congress 2015 – COPD: notable points Year: 2015 The therapeutic effects of zafirlukast on COPD induced pulmonary hypertension Source: Eur Respir J 2001; 18: Suppl. 33, 415s Year: 2001